An endogenous accelerator for viral gene expression confers a fitness advantage.
about
Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis.Immune Escape via a Transient Gene Expression Program Enables Productive Replication of a Latent Pathogen.Similarity in viral and host promoters couples viral reactivation with host cell migrationAn epistatic relationship between the viral protein kinase UL97 and the UL133-UL138 latency locus during the human cytomegalovirus lytic cycle.Antagonistic determinants controlling replicative and latent states of human cytomegalovirus infectionHuman cytomegalovirus inhibits apoptosis by regulating the activating transcription factor 5 signaling pathway in human malignant glioma cells.The 19S proteasome activator promotes human cytomegalovirus immediate early gene expression through proteolytic and nonproteolytic mechanisms.Mitogen and stress activated kinases act co-operatively with CREB during the induction of human cytomegalovirus immediate-early gene expression from latency.Tightly regulated expression of Autographa californica multicapsid nucleopolyhedrovirus immediate early genes emerges from their interactions and possible collective behaviors.Differentiation-Coupled Induction of Human Cytomegalovirus Replication by Union of the Major Enhancer Retinoic Acid, Cyclic AMP, and NF-κB Response Elements.Development of a high-throughput assay to measure the neutralization capability of anti-cytomegalovirus antibodies.An intein-mediated modulation of protein stability system and its application to study human cytomegalovirus essential gene function.The eIF4AIII RNA helicase is a critical determinant of human cytomegalovirus replication.The Microtubule Inhibitor Podofilox Inhibits an Early Entry Step of Human Cytomegalovirus.Convallatoxin-Induced Reduction of Methionine Import Effectively Inhibits Human Cytomegalovirus Infection and Replication.Oxidative stress-induced assembly of PML nuclear bodies controls sumoylation of partner proteins.Noise in multiple sclerosis: unwanted and necessary.Development of a high-content screen for the identification of inhibitors directed against the early steps of the cytomegalovirus infectious cycle.Insertion of myeloid-active elements into the human cytomegalovirus major immediate early promoter is not sufficient to drive its activation upon infection of undifferentiated myeloid cells.Fate-Regulating Circuits in Viruses: From Discovery to New Therapy Targets.Transient Thresholding: A Mechanism Enabling Noncooperative Transcriptional Circuitry to Form a Switch.Nuclear receptors control pro-viral and antiviral metabolic responses to hepatitis C virus infection.A Bioreactor Method to Generate High-titer, Genetically Stable, Clinical-isolate Human Cytomegalovirus.miRNA-mediated targeting of human cytomegalovirus reveals biological host and viral targets of IE2.A Post-Transcriptional Feedback Mechanism for Noise Suppression and Fate Stabilization.The Human Cytomegalovirus Strain DB Activates Oncogenic Pathways in Mammary Epithelial Cells.The transcriptome of human mammary epithelial cells infected with the HCMV-DB strain displays oncogenic traitsOvercoming the Cost of Positive Autoregulation by Accelerating the Response with a Coupled Negative Feedback
P2860
Q30352862-B2CA7AAC-A157-46C5-AEE6-DBFF3C5CF3A1Q30840932-16EF7EC5-D3E0-4D99-BA5E-17423E44D589Q33640033-76427BA0-98F4-4964-8BE2-64F7826537E0Q33887700-4C135B60-67FC-4EC7-BB3B-58EC15B72DB9Q33887823-5409A25B-368E-4CFA-8DE2-7D645998D070Q33967361-E2F90496-5625-40A7-9630-0473455FCDFDQ34261453-C0CE34F6-AE1F-47DA-8CE5-E5AAAC58032DQ35191037-E347CA2E-88E5-49F0-B6C5-B83740E71C1FQ35225243-D20BC1E6-028C-4086-B30B-EF81429119BCQ36334306-F767EECE-D5F5-4C1B-A597-ECFE637B9496Q36757818-89490E38-172E-409D-AA87-BCAEBB90BDFFQ36910786-4AA1D2E0-BDB0-4C2C-BEEB-6DC978320D04Q37003223-48CBA8BD-4689-41F9-BE48-4ACEFE96BB00Q37378850-81C8E8CF-765C-471F-A37D-40DD99ED0598Q37415371-1C7C0DAA-0075-4354-A506-DD6BC773957FQ37721763-B0DD3BDE-F1B8-4909-B6D0-12F36530DDB7Q38263875-A8F6FF81-EE00-49E5-B40E-19726D5B6359Q38935626-97DDCB85-DC4A-4D35-9DC7-E2267E5E6CE9Q39046934-743FF718-A40F-43F0-B5AC-40782C36F1EEQ40086009-08382710-C36D-4D3C-A31C-4AF9E2BE3166Q40168881-E73A1087-817D-4CB2-9958-575F076D21CDQ40490998-DA7FE06B-7988-4907-9961-37C85D116CDFQ46065213-D566A536-57D3-41F3-9AF5-88C0888174E7Q47552828-9BB7D610-68BA-4103-A9FE-C8A5DD80F2CCQ54213402-DBFA57BB-C02F-4DA6-9621-D8F2C4ED7700Q54239887-741943EE-8981-4717-B78F-7D2CABA4B2C7Q58327099-856E283A-8DC5-4262-96E2-02887FFD2C4DQ58749112-924390F3-C908-4044-BE1A-2DF6F6527A47
P2860
An endogenous accelerator for viral gene expression confers a fitness advantage.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
An endogenous accelerator for viral gene expression confers a fitness advantage.
@ast
An endogenous accelerator for viral gene expression confers a fitness advantage.
@en
type
label
An endogenous accelerator for viral gene expression confers a fitness advantage.
@ast
An endogenous accelerator for viral gene expression confers a fitness advantage.
@en
prefLabel
An endogenous accelerator for viral gene expression confers a fitness advantage.
@ast
An endogenous accelerator for viral gene expression confers a fitness advantage.
@en
P2093
P2860
P1433
P1476
An endogenous accelerator for viral gene expression confers a fitness advantage
@en
P2093
Andrew Womack
Cynthia Bolovan-Fritts
Leor S Weinberger
Melissa W Teng
Thomas Shenk
P2860
P304
P356
10.1016/J.CELL.2012.11.051
P407
P577
2012-12-01T00:00:00Z